SBI Pharmaceuticals And Nobelpharma Submit NDA In Japan For Oral Diagnostic Drug Aminolevulinic
This article was originally published in PharmAsia News
Executive Summary
SBI Pharmaceuticals and Nobelpharma announced July 6 they submitted a new drug application for an orally administered diagnostic drug used during surgery for malignant glioma.